STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13G/A] Core Laboratories Inc. /DE/ SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary

Core Laboratories Inc. (CLB): The Vanguard Group filed Amendment No. 3 to Schedule 13G, reporting beneficial ownership of 3,047,390 shares of common stock, representing 6.49% of the class as of 09/30/2025.

Vanguard reports 0 shares with sole voting power and 287,217 shares with shared voting power. It has 2,714,143 shares with sole dispositive power and 333,247 shares with shared dispositive power. Vanguard is identified as an investment adviser (IA), and states the securities were acquired and are held in the ordinary course of business. Vanguard’s clients have the right to receive dividends or sale proceeds related to these shares, and no single client’s interest exceeds 5%. The filing includes a certification that the holdings were not acquired to change or influence control of the issuer.

Positive
  • None.
Negative
  • None.

Insights

Passive 13G/A shows Vanguard at 6.49% of CLB.

The Vanguard Group disclosed beneficial ownership of 3,047,390 shares of Core Laboratories, or 6.49%, as of 09/30/2025. The filing is on Schedule 13G/A, indicating a passive intent.

Voting rights are limited: 0 shares with sole voting power and 287,217 with shared voting power. Dispositive power is primarily sole (2,714,143 shares), with 333,247 shared, consistent with an investment adviser structure.

The certification states the position was acquired in the ordinary course and not to influence control. Vanguard notes client economic rights and that no single client exceeds 5%. Actual trading implications depend on future portfolio decisions by clients and the adviser.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:10/30/2025
Core Laboratories Inc

NYSE:CLB

CLB Rankings

CLB Latest News

CLB Latest SEC Filings

CLB Stock Data

742.22M
46.07M
1.01%
114.69%
17.73%
Oil & Gas Equipment & Services
Oil & Gas Field Services, Nec
Link
United States
HOUSTON